UsesDirections for UseRoute of AdministrationSide EffectsMedicine ActivityPrecautions & WarningsInteractionsDosageStorageSpecial Dietary And Lifestyle RecommendationFact BoxFAQs MAXILIV INJECTION 1 is used to manage glutathione deficiency in liver disorders and to provide antioxidant support
Discontinuation rates due to adverse events were 2.2%, 4.5%, and 5.1% with retatrutide, respectively, compared with 0.0% with placebo
doi: 10.3390/nu11051136
Growth hormone secretagogue (GHRH analog) vs Growth hormone secretagogue (GHRH analog)
In addition, TMAO may accelerate the process of atherosclerosis and increase the risk of cardiovascular diseases through mechanisms such as promoting inflammation, increasing the expression of scavenger receptors, inhibiting reverse cholesterol transport, and enhancing vascular calcification (Luo et al., 2024)
During pregnancy, maternal metabolism changes significantly, and fetal development depends on precise glucose regulation and nutrient balance